Molecule Structure

Scientific Name

Rifaximin

Description of the Drug

Rifaximin is a rifamycin-based non-systemic antibiotic used for the treatment of gastrointestinal bacterial infections, such as traveler’s diarrhea and irritable bowel syndrome, and reduction of overt hepatic encephalopathy recurrence in adults.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01220

Brand Name(s)

Normix, Rifacol, Targaxan, Xifaxan, Xifaxanta

Company Owner(s)

Salix Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial DNA-directed RNA polymerase PROTEIN COMPLEX INHIBITOR CHEMBL2364672

Unichem Links

SureChEMBL SCHEMBL124066
PharmGKB PA164752443
DrugBank DB01220
PubChem: Thomson Pharma 14864870 14864871
PubChem 6436173
Mcule MCULE-7361349450
PDBe RXM
BindingDB 50347620
EPA CompTox Dashboard DTXSID7045998
DrugCentral 2379
ChemicalBook CB5244184
rxnorm RIFAXIMIN XIFAXAN
PubChem: Drugs of the Future 12012727
ChEBI 75246
ZINC ZINC000169621200